HAE - Haemonetics 3rd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website

PR Newswire

Financial release accessible online

BOSTON , Feb. 8, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its third quarter fiscal year 2024, which ended December 30, 2023 , are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on February 8, 2024 . The conference call and webcast can be accessed with the following information:

• Teleconference link: https://register.vevent.com/register/BIddeef4a5eb8d4c2d96bcf82386d2a73e
• Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.
• A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/unynzc8w

In addition, the Company has posted to its Investor Relations website the earnings release that will be referenced on its conference call and webcast, a link to which is available below.

Direct link to 3Q FY24 Earnings Release :
https://haemonetics.gcs-web.com/static-files/7edda7ff-7ea8-4178-b828-abcfcbafec7c

A replay of the conference call and webcast will be available for one year beginning on February 8, 2024 , at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com .

SOURCE Haemonetics Corporation